USX:AUTL - Autolus Therapeutics PLC

Autolus Therapeutics Ltd
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance (Live Price)

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts
• Options

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2016 Q3	2017 Q3	2018 Q1	2018 Q3	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	26.09% 2.0%	25.58% -2.0%	25.23% -1.4%	16.09% -36.2%	16.09% 0%	16.08% 0.0%	8.8% -45.3%	8.45% -4.0%	8.45% 0%	8.45% 0%	8.45% 0%	-
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-8.38K% -	-9.51K% -	-6.1K% -	-6.26K% -	-18.81K% -	-5.12K% -	-2.4K% -	-2.02K% -	-2.07K% -	-2.86K% -	-12.27K% -	-2.11K% -
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-9.55K% -	-10.92K% -	-7.05K% -	-7.16K% -	-21.34K% -	-5.6K% -	-2.7K% -	-2.21K% -	-2.22K% -	-3.09K% -	-10.34K% -	-1.7K% -
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.75M 911.0%	1.51M -13.8%	2.33M 54.6%	2.33M 0%	823K -64.7%	3.19M 287.8%	6.19M 94.0%	7.49M 20.9%	7.49M 0%	5.52M -26.2%	1.7M -69.3%	-
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	330.65M -5.5%	296.64M -10.3%	405.56M 36.7%	363.99M -10.2%	313.98M -13.7%	263.83M -16.0%	490.27M 85.8%	459.97M -6.2%	450.99M -2.0%	406.1M -10.0%	375.38M -7.6%	901.44M 140.1%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	46.97M -6.4%	51.91M 10.5%	92.24M 77.7%	92.85M 0.7%	99.45M 7.1%	102.68M 3.2%	191.6M 86.6%	193.05M 0.8%	221.66M 14.8%	225.58M 1.8%	263.91M 17.0%	319.41M 21.0%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	283.68M -5.3%	244.73M -13.7%	313.32M 28.0%	271.14M -13.5%	214.52M -20.9%	161.15M -24.9%	298.67M 85.3%	266.92M -10.6%	229.34M -14.1%	180.52M -21.3%	111.47M -38.2%	582.03M 422.1%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-140.75M -	-136.43M -	-117.86M -	-115.55M -	-109.75M -	-106.9M -	-112.31M -	-119.7M -	-127.04M -	-135.32M -	-145.59M -	-143.68M -
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	212.83M -12.8%	178.48M -16.1%	154.09M -13.7%	239.8M 55.6%	216.56M -9.7%	173.27M -20.0%	310.68M 79.3%	268.89M -13.4%	216.76M -19.4%	163.37M -24.6%	382.76M 134.3%	343.36M -10.3%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	196.43M -11.7%	166.34M -15.3%	310.68M 86.8%	277.26M -10.8%	245.14M -11.6%	202.09M -17.6%	382.76M 89.4%	358.42M -6.4%	296.99M -17.1%	240.51M -19.0%	240.34M -0.1%	753.02M 213.3%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-153.68M -	-149.18M -	-126.72M -	-123.28M -	-118.6M -	-118.69M -	-123.15M -	-133.39M -	-142.48M -	-145.46M -	-156.57M -	-151.58M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-146.62M -	-143.29M -	-142.1M -	-145.89M -	-154.78M -	-163.55M -	-148.84M -	-151.59M -	-155.08M -	-158.16M -	-208.38M -	-221.26M -
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-146.62M -	-143.29M -	-142.1M -	-145.89M -	-154.78M -	-163.55M -	-148.84M -	-151.59M -	-155.08M -	-158.16M -	-208.38M -	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-2.54 -	-2.29 -	-1.97 -	-1.85 -	-1.84 -	-1.85 -	-1.57 -	-1.39 -	-1.19 -	-0.98 -	-1.2 -	-
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-54.04% -	-59.51% -	-54.3% -	-51.13% -	-62.13% -	-80.59% -	-48.64% -	-56.35% -	-69.88% -	-92.58% -	-101.61% -	-52.13% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-45.73% -	-46.7% -	-40.61% -	-40.88% -	-48.02% -	-58.36% -	-33.23% -	-36.79% -	-40.55% -	-47.22% -	-48.14% -	-32.5% -